You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Colorcon
Baxter
Dow
Express Scripts

Last Updated: August 6, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Carfentanil

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Carfentanil?

Carfentanil is an investigational drug.

There have been 9 clinical trials for Carfentanil. The most recent clinical trial was a Phase 1 trial, which was initiated on April 1st 2012.

The most common disease conditions in clinical trials are Tobacco Use Disorder, Depression, and Substance-Related Disorders. The leading clinical trial sponsors are Johns Hopkins University, National Institute on Drug Abuse (NIDA), and Yale University.

There are four hundred and four US patents protecting this investigational drug and three international patents.

Recent Clinical Trials for Carfentanil
TitleSponsorPhase
Effects of Experimental Sleep Disturbances on Receptor Function of Study DrugNational Heart, Lung, and Blood Institute (NHLBI)Phase 2
Effects of Experimental Sleep Disturbances on Receptor Function of Study DrugJohns Hopkins UniversityPhase 2
Neurobiology of Treatment Responses in MDDUniversity of UtahPhase 3

See all Carfentanil clinical trials

Clinical Trial Summary for Carfentanil

Top disease conditions for Carfentanil
Top clinical trial sponsors for Carfentanil

See all Carfentanil clinical trials

US Patents for Carfentanil

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Carfentanil   Start Trial Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse Acura Pharmaceuticals, Inc. (Palatine, IL)   Start Trial
Carfentanil   Start Trial Transdermal dosage form Barr Laboratories, Inc. (Pomona, NY)   Start Trial
Carfentanil   Start Trial Self-expanding devices and methods therefor Intersect ENT, Inc. (Menlo Park, CA)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Colorcon
Baxter
Dow
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.